|0.65|| -0.0214 / -3.19%|
Implant Sciences Corp. designs, manufactures, and sells explosives trace detection (ETD) and drugs trace detection solutions for multiple security applications including aviation, transportation, customs, air cargo, critical infrastructure protection, ports and borders, force protection, public safety and emergency responders. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial and improvised explosives, as well as narcotics. The company was founded in August 1984 and is headquartered in Wilmington, MA.
|William J. McGann||Chief Executive Officer & Director|
|Robert P. Liscouski||President & Director|
|Todd A. Silvestri||Chief Operating Officer|
|Roger P. Deschenes||Chief Financial Officer & Vice President|
|Brenda L. Baron||Vice President-Manufacturing & Technical Services|